In contrast, WDR5, a component of WRAD complex, has been reported to act as an oncoprotein in prostate cancer, in which it is overexpressed and crucial for the androgen-induced proliferation of tumor cells [21]. This evidence concerns the gene WDR5 and prostate carcinoma.